The cell cycle regulator cyclin-dependent kinase 6 (Cdk6) is also known to be significantly upregulated in glioma cells, and its elevated expression correlates with the grades of glioma malignancy and glioma resistance to chemotherapy (Lu et al., 2018). Here, CDK6 is linked to glioma.